In the study conducted by Aslan et al., patients with chronic otitis media with and without tympanosclerosis were discussed, MMP-2 and MMP-9 levels in serum were measured more than healthy people, and it was concluded that enzymes that inhibit them could be used in treatment [22]. The gene discussed is MMP9; the disease is middle ear disorder.